UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy

Circulation (New York, N.Y.), 1992-08, Vol.86 (2), p.426-430

1992

Volltextzugriff (PDF)

Sustained Inhibition of Angiotensin I-Converting Enzyme (ACE) Expression and Long-Term Antihypertensive Action by Virally Mediated Delivery of ACE Antisense cDNA

Circulation research, 1999-10, Vol.85 (7), p.614-622

1999

Volltextzugriff (PDF)

Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertension

Journal of hypertension, 2000-04, Vol.18 (4), p.353-362

2000

Volltextzugriff (PDF)

Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring

Circulation research, 1999-11, Vol.85 (10), p.e44-e50

1999

Volltextzugriff (PDF)

Angiotensin II Type 1 Receptor Antisense Gene Therapy Prevents Altered Renal Vascular Calcium Homeostasis in Hypertension

Hypertension (Dallas, Tex. 1979), 1999-01, Vol.33 (1S Suppl), p.360-365

1999

Volltextzugriff (PDF)

Prevention of Renovascular and Cardiac Pathophysiological Changes in Hypertension by Angiotensin II type 1 Receptor Antisense Gene Therapy

Proceedings of the National Academy of Sciences - PNAS, 1998-03, Vol.95 (5), p.2664-2669

1998

Volltextzugriff (PDF)

Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension

Journal of hypertension, 2001-09, Vol.19 (9), p.1553-1558

2001

Volltextzugriff (PDF)

Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension

Hypertension (Dallas, Tex. 1979), 2004-02, Vol.43 (2, Part 2), p.324-328

2004

Volltextzugriff (PDF)

Endothelial-independent prevention of high blood pressure in L-NAME-treated rats by angiotensin II type I receptor antisense gene therapy

Experimental physiology, 2003-07, Vol.88 (4), p.467-473

2003

Volltextzugriff (PDF)

Angiotensin I–Converting Enzyme Antisense Gene Therapy Causes Permanent Antihypertensive Effects in the SHR

Hypertension (Dallas, Tex. 1979), 2000-01, Vol.35 (1, Part 2 Suppl), p.202-202

2000

Volltextzugriff (PDF)

Attenuation of Hypertension by Systemic Delivery of Retroviral Vector Containing Type I Angiotensin II Receptor Antisense cDNA

Methods (San Diego, Calif.), 2000-11, Vol.22 (3), p.211-218

2000

Volltextzugriff (PDF)

Angiotensin I–Converting Enzyme Antisense Prevents Altered Renal Vascular Reactivity, but Not High Blood Pressure, in Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 2000-01, Vol.35 (1, Part 2 Suppl), p.209-209

2000

Volltextzugriff (PDF)

[32] Large-scale production of retroviral vectors for systemic gene delivery

Methods in Enzymology, 2002, Vol.346, p.562-573

2002

Volltextzugriff (PDF)

Retrovirally mediated delivery of angiotensin II type 1 receptor antisense in vitro and in vivo

Methods in enzymology, 2000, Vol.314, p.581-590

2000

Volltextzugriff (PDF)

Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR: Proceedings of the Council for High Blood Pressure Research, 1999

Hypertension (Dallas, Tex. 1979), 2000, Vol.35 (1), p.202-208

2000

Volltextzugriff (PDF)

Angiotensin I-converting enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats: Proceedings of the Council for High Blood Pressure Research, 1999

Hypertension (Dallas, Tex. 1979), 2000, Vol.35 (1), p.209-213

2000

Volltextzugriff (PDF)

Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors

Haematologica (Roma), 2020-01, Vol.105 (1), p.218-225

2020

Volltextzugriff (PDF)

The effects of conformation and intermolecular hydrogen bonding on the structure and IR spectra of flutamide; a study based on the matrix isolation technique, ab initio and DFT calculations

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2023-05, Vol.292, p.122417, Article 122417

2023

Volltextzugriff (PDF)

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1

American journal of ophthalmology, 2003-09, Vol.136 (3), p.407-418

2003

Volltextzugriff (PDF)

Regulation of Intestinal Apolipoprotein B mRNA Editing Levels by a Zinc-Deficient Diet and cDNA Cloning of Editing Protein in Hamsters

The Journal of nutrition, 2000-09, Vol.130 (9), p.2166-2173

2000

Volltextzugriff (PDF)

Zinc deficiency decreases plasma level and hepatic mRNA abundance of apolipoprotein A-I in rats and hamsters

American Journal of Physiology: Cell Physiology, 1998-12, Vol.275 (6), p.C1516-C1525

1998

Volltextzugriff (PDF)

Apolipoprotein A-I gene expression is regulated by cellular zinc status in Hep G2 cells

American Journal of Physiology: Cell Physiology, 1999-09, Vol.277 (3), p.C537-C544

1999

Volltextzugriff (PDF)

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes

Retina (Philadelphia, Pa.), 2002-02, Vol.22 (1), p.6

2002

Volltextzugriff (PDF)

Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine

American Journal of Physiology: Cell Physiology, 1997-10, Vol.273 (4), p.C1362-C1370

1997

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(36)
Tagungsberichte
(3)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy

Sustained Inhibition of Angiotensin I-Converting Enzyme (ACE) Expression and Long-Term Antihypertensive Action by Virally Mediated Delivery of ACE Antisense cDNA

Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertension

Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring

Angiotensin II Type 1 Receptor Antisense Gene Therapy Prevents Altered Renal Vascular Calcium Homeostasis in Hypertension

Prevention of Renovascular and Cardiac Pathophysiological Changes in Hypertension by Angiotensin II type 1 Receptor Antisense Gene Therapy

Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension

Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension

Endothelial-independent prevention of high blood pressure in L-NAME-treated rats by angiotensin II type I receptor antisense gene therapy

Angiotensin I–Converting Enzyme Antisense Gene Therapy Causes Permanent Antihypertensive Effects in the SHR

Attenuation of Hypertension by Systemic Delivery of Retroviral Vector Containing Type I Angiotensin II Receptor Antisense cDNA

Angiotensin I–Converting Enzyme Antisense Prevents Altered Renal Vascular Reactivity, but Not High Blood Pressure, in Spontaneously Hypertensive Rats

[32] Large-scale production of retroviral vectors for systemic gene delivery

Retrovirally mediated delivery of angiotensin II type 1 receptor antisense in vitro and in vivo

Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR: Proceedings of the Council for High Blood Pressure Research, 1999

Angiotensin I-converting enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats: Proceedings of the Council for High Blood Pressure Research, 1999

Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors

The effects of conformation and intermolecular hydrogen bonding on the structure and IR spectra of flutamide; a study based on the matrix isolation technique, ab initio and DFT calculations

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1

Regulation of Intestinal Apolipoprotein B mRNA Editing Levels by a Zinc-Deficient Diet and cDNA Cloning of Editing Protein in Hamsters

Zinc deficiency decreases plasma level and hepatic mRNA abundance of apolipoprotein A-I in rats and hamsters

Apolipoprotein A-I gene expression is regulated by cellular zinc status in Hep G2 cells

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes

Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine

Suchergebnisse filtern